CIK 0001637715 · <br>Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472309515
- Phone
- (720) 307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,157
- in 2 filings
Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-31 | GREY MICHAEL G Executive Chairman | Option exercise | +50,000 | $1.97 | $99K | 50,000 |
| 2022-08-31 | GREY MICHAEL G Executive Chairman | Option exercise · Stock option (right to buy) | −50,000 | 67,406 | ||
| 2022-08-31 | Cruse Michael Chief Operating Officer | Purchase | +3,212 | $3.21 | $10K | 6,197 |
| 2022-08-30 | Cruse Michael Chief Operating Officer | Purchase | +975 | $3.16 | $3K | 31,758 |
| 2022-08-30 | Cruse Michael Chief Operating Officer | Purchase | +1,845 | $3.19 | $6K | 2,985 |
| 2022-08-29 | Cruse Michael Chief Operating Officer | Purchase | +83 | $3.24 | $269 | 30,783 |
| 2022-08-29 | Cruse Michael Chief Operating Officer | Purchase | +1,140 | $3.24 | $4K | 1,140 |
| 2022-08-12 | Dorenbaum Alejandro Chief Medical Officer | Gift | −22,348 | 30,000 | ||
| 2022-08-02 | Blunt Roshawn A. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-01 | Mathers Edward T Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2022-06-01 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2022-06-01 | Hoelscher Paul W. Director | Grant or award · Stock Option (right to buy) | +6,376 | 6,376 | ||
| 2022-06-01 | Dube Eric M Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2022-06-01 | Muralidhar Bali Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 |
Page 8 of 8 · 154 trades